Whole-exome sequencing (WES) using next-generation sequencing (NGS) technology is a powerful tool for investigating variants linked to genetic disease. It…

Next-generation sequencing (NGS) techniques allow high-throughput detection of a vast amount of genetic variations in a cost-effective manner. However, there…

Hint: The secret is in the biological context Today’s discovery scientists are challenged with identifying new biomarkers and therapeutic targets…

Read about how researchers across the world are using QIAGEN Digital Insights solutions to accelerate their work in a variety…

The Winter 2020 Release of the Human Gene Mutation Database (HGMD) Professional is available, expanding the world’s largest collection of…

Check out the new features of QIAGEN CLC Genomics Are you struggling to find a bioinformatics analysis tool that meets…

Read about how researchers across the world are using QIAGEN Digital Insights solutions to accelerate their work in a variety…

Discover more about the latest QCI update and how the platform simplifies and accelerates NGS variant analysis, interpretation, and reporting…

Today genetic innovation is advancing at breakneck pace. Since the first whole genome was sequenced in 2003, a feat that…

We are excited to announce the general availability of the Fall 2020 Release of QIAGEN Clinical Insight (QCI) Interpret. This…

Introducing QCI Interpret Translational, a new software solution for NGS variant assessment Whole-exome sequencing (WES) using next-generation sequencing (NGS) technology…

Recently, there have been many noteworthy papers citing QIAGEN CLC Genomics Workbench, a comprehensive, easy-to-use toolbox that ensures continuity in…